Panther Pharmaceuticals, Inc. — Form D
Panther Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-23. The offering totals $500K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-23
- Form: D
- Accession: 0001732524-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $200K
- Remaining: $300K
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2018-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306279
Issuer
- Name: Panther Pharmaceuticals, Inc.
- CIK: 0001732524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 301-204-6781
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Per Lindell | Director | Cambridge, MA |
| Michael Tolentino | Director | Cambridge, MA |
| Per Lindell | Executive Officer | Cambridge, MA |
More